USPTO serial 78357607
TARGETED MEDICINES BY DESIGN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMAS, AMY E
- Law office
- TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TARGETED MEDICINES BY DESIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Toronto, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John A. Clifford
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives | ACTIVE | — |
| 042 | Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 25, 2006 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 25, 2006 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 27, 2005 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Sep 27, 2005 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 24, 2005 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 14, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 13, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 11, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 25, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2005 | PAPER RECEIVED | — | |
| Aug 19, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2004 | NWAP | NEW APPLICATION ENTERED | — |